Verastem, Inc. (VSTM) financial statements (2021 and earlier)

Company profile

Business Address 117 KENDRICK STREET
NEEDHAM, MA 02494
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:148111250878111093
Cash and cash equivalents684413082322534
Short-term investments73321204498559
Other undisclosed cash, cash equivalents, and short-term investments63600   
Receivables    000
Inventory, net of allowances, customer advances and progress billings 30    
Inventory 30    
Prepaid expense    000
Other undisclosed current assets(3)(29)31002
Total current assets:14585253888111195
Noncurrent Assets
Operating lease, right-of-use asset33
Property, plant and equipment0111123
Long-term investments and receivables6      
Long-term investments6      
Intangible assets, net (including goodwill) 2022    
Intangible assets, net (excluding goodwill) 2022    
Restricted cash and investments035 0000
Other noncurrent assets01111 0
Total noncurrent assets:960242223
TOTAL ASSETS:154145277908411399
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities17293117111011
Accounts payable210109443
Accrued liabilities1519218766
Employee-related liabilities      2
Debt 06    
Deferred compensation liability     00
Derivative instruments and hedges, liabilities 0     
Deferred revenue and credits   0
Other liabilities      1
Other undisclosed current liabilities1     (3)
Total current liabilities:1730371711109
Noncurrent Liabilities
Long-term debt and lease obligation2210711515   
Long-term debt, excluding current maturities1910411515   
Operating lease, liability33
Liabilities, other than long-term debt 1100  
Other liabilities 1100  
Other undisclosed noncurrent liabilities(3)      
Total noncurrent liabilities:22108116150  
Total liabilities:391381533211109
Stockholders' equity
Stockholders' equity attributable to parent1157124587210289
Common stock0000000
Additional paid in capital708532500361308301230
Accumulated other comprehensive income (loss)000(0)000
Accumulated deficit(593)(525)(376)(303)(235)(199)(141)
Total stockholders' equity:1157124587210289
Other undisclosed liabilities and equity     11
TOTAL LIABILITIES AND EQUITY:154145277908411399

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues891727    
Cost of revenue(28)(3)(0)    
Cost of goods and services sold(1)(2)(0)    
Gross profit:601527    
Operating expenses(110)(147)(122)(68)(37)(58)(54)
Other undisclosed operating income  0    
Operating loss:(49)(132)(95)(68)(37)(58)(54)
Nonoperating income (expense)(1)4281100
Investment income, nonoperating1431100
Other nonoperating income (expense)(1)(1)26    
Interest and debt expense(17)(21)(6)(1)   
Loss from continuing operations before income taxes:(68)(149)(72)(68)(36)(58)(53)
Income tax expense(0)      
Net loss available to common stockholders, basic:(68)(149)(72)(68)(36)(58)(53)
Interest on convertible debt  3    
Other undisclosed net loss available to common stockholders, diluted  (26)    
Net loss available to common stockholders, diluted:(68)(149)(95)(68)(36)(58)(53)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(68)(149)(72)(68)(36)(58)(53)
Comprehensive loss:(68)(149)(72)(68)(36)(58)(53)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)0(0)(0)0(0)
Comprehensive loss, net of tax, attributable to parent:(68)(149)(72)(68)(36)(58)(53)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: